Calithera Biosciences Inc (CALA) stock is down -82.08% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CALA stock a score of 32 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 1. CALA's rank also includes a long-term technical score of 5. The fundamental score for CALA is 89. In addition to the average rating from Wall Street analysts, CALA stock has a mean target price of $2.17. This means analysts expect the stock to increase 470.00% over the next 12 months. CALA has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on CALA!